Nakagawa H - Search Results

1

Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8⁺ T cells.

Mizukoshi E, Nakagawa H, Tamai T, Kitahara M, Fushimi K, Nio K, Terashima T, Iida N, Arai K, Yamashita T, Yamashita T, Sakai Y, Honda M, Kaneko S. Mizukoshi E, et al. Among authors: nakagawa h. Nat Commun. 2022 Jun 3;13(1):3123. doi: 10.1038/s41467-022-30861-z. Nat Commun. 2022. PMID: 35660746 Free PMC article.

2

Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alpha.

Iida N, Nakamoto Y, Baba T, Nakagawa H, Mizukoshi E, Naito M, Mukaida N, Kaneko S. Iida N, et al. Among authors: nakagawa h. Cancer Res. 2010 Aug 15;70(16):6556-65. doi: 10.1158/0008-5472.CAN-10-0096. Epub 2010 Jul 27. Cancer Res. 2010. PMID: 20663902

3

A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.

Kobayashi E, Mizukoshi E, Kishi H, Ozawa T, Hamana H, Nagai T, Nakagawa H, Jin A, Kaneko S, Muraguchi A. Kobayashi E, et al. Among authors: nakagawa h. Nat Med. 2013 Nov;19(11):1542-6. doi: 10.1038/nm.3358. Epub 2013 Oct 13. Nat Med. 2013. PMID: 24121927

4

Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.

Terashima T, Yamashita T, Arai K, Sunagozaka H, Kitahara M, Nakagawa H, Kagaya T, Mizukoshi E, Honda M, Kaneko S. Terashima T, et al. Among authors: nakagawa h. Hepatol Res. 2014 Nov;44(12):1179-85. doi: 10.1111/hepr.12266. Epub 2014 Jan 8. Hepatol Res. 2014. PMID: 24171787 Free article.

5

In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.

Nakagawa H, Mizukoshi E, Iida N, Terashima T, Kitahara M, Marukawa Y, Kitamura K, Nakamoto Y, Hiroishi K, Imawari M, Kaneko S. Nakagawa H, et al. Cancer Immunol Immunother. 2014 Apr;63(4):347-56. doi: 10.1007/s00262-013-1514-7. Epub 2014 Jan 3. Cancer Immunol Immunother. 2014. PMID: 24384836 Free PMC article.

6

Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.

Terashima T, Yamashita T, Iida N, Yamashita T, Nakagawa H, Arai K, Kitamura K, Kagaya T, Sakai Y, Mizukoshi E, Honda M, Kaneko S. Terashima T, et al. Among authors: nakagawa h. Hepatol Res. 2015 Sep;45(9):949-959. doi: 10.1111/hepr.12436. Epub 2014 Nov 17. Hepatol Res. 2015. PMID: 25319848

7

Immunological features of T cells induced by human telomerase reverse transcriptase-derived peptides in patients with hepatocellular carcinoma.

Mizukoshi E, Nakagawa H, Kitahara M, Yamashita T, Arai K, Sunagozaka H, Fushimi K, Kobayashi E, Kishi H, Muraguchi A, Kaneko S. Mizukoshi E, et al. Among authors: nakagawa h. Cancer Lett. 2015 Aug 10;364(2):98-105. doi: 10.1016/j.canlet.2015.04.031. Epub 2015 May 14. Cancer Lett. 2015. PMID: 25982205

8

Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma.

Mizukoshi E, Nakagawa H, Kitahara M, Yamashita T, Arai K, Sunagozaka H, Iida N, Fushimi K, Kaneko S. Mizukoshi E, et al. Among authors: nakagawa h. Cancer Lett. 2015 Dec 1;369(1):242-9. doi: 10.1016/j.canlet.2015.08.020. Epub 2015 Sep 1. Cancer Lett. 2015. PMID: 26325606 Clinical Trial.

9

Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib.

Terashima T, Yamashita T, Takata N, Nakagawa H, Toyama T, Arai K, Kitamura K, Yamashita T, Sakai Y, Mizukoshi E, Honda M, Kaneko S. Terashima T, et al. Among authors: nakagawa h. Hepatol Res. 2016 Jun;46(7):650-6. doi: 10.1111/hepr.12601. Epub 2015 Nov 2. Hepatol Res. 2016. PMID: 26441378

10

Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.

Mizukoshi E, Yamashita T, Arai K, Terashima T, Kitahara M, Nakagawa H, Iida N, Fushimi K, Kaneko S. Mizukoshi E, et al. Among authors: nakagawa h. Cancer Immunol Immunother. 2016 Jun;65(6):715-25. doi: 10.1007/s00262-016-1837-2. Epub 2016 Apr 15. Cancer Immunol Immunother. 2016. PMID: 27083166 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,314 results

Search Page

Filters